News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors. Her strategic insights will be key as we advance our late stage pipeline of agents with the potential to bec…

Prof Paul Peter Tak: Rheumatology, Real Impact and Comfort Zones

Prof Paul Peter Tak is my guest on the podcast this week. He talks to me about growing up in the Netherlands. his medical career and how he ended up specializing in Rheumatology. We chat about his i…

The Story of Flagship Pioneering and The Future of Medicines

James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics. Over a more than 25-year career in the life sciences, Paul-Peter has created and le…

Careers in Discovery

Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influen…

Listen Notes: Paul-Peter Tak, Academic, business leader and biotech entrepreneur

In this episode, Paul-Peter Tak joins Monica Westley to discuss his innovative ideas within the type 1 diabetes space and how immunology can play a role in helping find a cure for T1D. Paul-Peter is…

Podomatic: Paul-Peter Tak

In biotech, DR. PAUL-PETER TAK, the CEO of Kintai Therapeutics gives us a bigger picture of our gut – it’s not just your microbiome that plays a significant role in the recovery from illness. Lis…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.